BDBM463251 4-Amino-5-(5-chloro-4- hydroxypyridin-2-yl)-2-(8- (cyclohexylmethyl)- [1,2,4]triazolo[1,5-a]pyrazin-6- yl)-5-methyl-5,7-dihydro-6H- pyrrolo[2,3-d]pyrimidin-6-one::US10780092, Example 105-B

SMILES CC1(C(=O)Nc2nc(nc(N)c12)-c1cn2ncnc2c(CC2CCCCC2)n1)c1cc(O)c(Cl)cn1

InChI Key InChIKey=IWEYVBJCPKBIFE-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 463251   

TargetGuanylate cyclase soluble subunit alpha-1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM463251(4-Amino-5-(5-chloro-4- hydroxypyridin-2-yl)-2-(8- ...)
Affinity DataKi:  0.213nMAssay Description:The binding potencies of sGC compounds to the human recombinant sGC enzyme were determined in a Size Exclusion Chromatography (SEC) competition bindi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2021
Entry Details
US Patent